The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos
The Oncology Institute (NASDAQ: TOI) has announced the launch of its Lung Cancer Center of Excellence in Fort Lauderdale, Florida. The center will be led by renowned thoracic oncologist Dr. Edgardo S. Santos Castillero, an internationally recognized expert in the field.
The new center aims to provide advanced cancer treatments and clinical trials in a community-based setting, making high-quality care more accessible to Florida patients. Dr. Santos brings extensive experience from leadership roles at prestigious institutions including Tulane University and the University of Miami/Sylvester Comprehensive Cancer Center.
This initiative aligns with TOI's mission to expand access to value-based oncology care while reducing financial burden for patients and payors.
The Oncology Institute (NASDAQ: TOI) ha annunciato l'apertura del suo Lung Cancer Center of Excellence a Fort Lauderdale, Florida. Il centro sarà diretto dal noto oncologo toracico Dr. Edgardo S. Santos Castillero, riconosciuto a livello internazionale nel settore.
La struttura offrirà trattamenti oncologici avanzati e studi clinici in un contesto radicato nella comunità, rendendo cure di alta qualità più accessibili ai pazienti della Florida. Il Dr. Santos vanta un'ampia esperienza maturata in ruoli di leadership presso istituzioni prestigiose come Tulane University e University of Miami/Sylvester Comprehensive Cancer Center.
Questa iniziativa è in linea con la missione di TOI di ampliare l'accesso a cure oncologiche basate sul valore, riducendo al contempo l'onere finanziario per pazienti e pagatori.
The Oncology Institute (NASDAQ: TOI) ha anunciado la apertura de su Lung Cancer Center of Excellence en Fort Lauderdale, Florida. El centro estará dirigido por el reconocido oncólogo torácico Dr. Edgardo S. Santos Castillero, experto de prestigio internacional.
El nuevo centro ofrecerá tratamientos oncológicos avanzados y ensayos clínicos en un entorno comunitario, haciendo que la atención de alta calidad sea más accesible para los pacientes de Florida. El Dr. Santos aporta amplia experiencia en puestos de liderazgo en instituciones destacadas como Tulane University y University of Miami/Sylvester Comprehensive Cancer Center.
Esta iniciativa coincide con la misión de TOI de ampliar el acceso a una atención oncológica basada en el valor, al tiempo que reduce la carga financiera para pacientes y pagadores.
The Oncology Institute (NASDAQ: TOI)는 플로리다 포트로더데일에 Lung Cancer Center of Excellence를 개설한다고 발표했습니다. 센터는 폐암 분야의 국제적 권위자이자 저명한 흉부종양학자 Dr. Edgardo S. Santos Castillero가 이끌 예정입니다.
새 센터는 지역사회 기반 환경에서 첨단 암 치료와 임상시험을 제공하여 플로리다 환자들이 양질의 치료를 보다 쉽게 받을 수 있도록 하는 것을 목표로 합니다. Santos 박사는 Tulane University와 University of Miami/Sylvester Comprehensive Cancer Center 등 유수 기관에서의 리더십 경험을 보유하고 있습니다.
이번 사업은 가치 기반 암 치료에 대한 접근성을 확대하고 환자 및 보험자의 재정적 부담을 줄이려는 TOI의 목표와 부합합니다.
The Oncology Institute (NASDAQ: TOI) a annoncé le lancement de son Lung Cancer Center of Excellence à Fort Lauderdale, en Floride. Le centre sera dirigé par le réputé oncologue thoracique Dr. Edgardo S. Santos Castillero, expert de renommée internationale.
Ce nouveau centre vise à offrir des traitements anticancéreux avancés et des essais cliniques dans un cadre de proximité, afin de rendre des soins de haute qualité plus accessibles aux patients de Floride. Le Dr Santos apporte une vaste expérience acquise lors de fonctions de direction dans des institutions prestigieuses telles que Tulane University et University of Miami/Sylvester Comprehensive Cancer Center.
Cette initiative s'inscrit dans la mission de TOI d'élargir l'accès à des soins oncologiques axés sur la valeur, tout en réduisant le fardeau financier des patients et des payeurs.
The Oncology Institute (NASDAQ: TOI) hat die Eröffnung seines Lung Cancer Center of Excellence in Fort Lauderdale, Florida, bekanntgegeben. Geleitet wird das Zentrum von dem renommierten Thoraxonkologen Dr. Edgardo S. Santos Castillero, einem international anerkannten Experten auf dem Gebiet.
Das neue Zentrum will fortschrittliche Krebstherapien und klinische Studien in einem gemeindenahen Umfeld anbieten und so hochwertige Versorgung für Patienten in Florida besser zugänglich machen. Dr. Santos bringt umfangreiche Erfahrung aus Führungspositionen an angesehenen Einrichtungen wie der Tulane University und dem University of Miami/Sylvester Comprehensive Cancer Center mit.
Die Initiative steht im Einklang mit der Mission von TOI, den Zugang zu wertorientierter onkologischer Versorgung zu erweitern und gleichzeitig die finanzielle Belastung für Patienten und Kostenträger zu verringern.
- Expansion of specialized cancer care services in Florida market
- Addition of internationally renowned expert Dr. Santos to lead the center
- Enhanced access to advanced treatments and clinical trials in community setting
- None.
Insights
TOI's new Lung Cancer Center in Florida enhances value-based care capabilities and expands specialized services with top-tier expertise.
This strategic expansion by The Oncology Institute represents a calculated move to strengthen their specialized cancer care offerings in the Florida market. By establishing a Lung Cancer Center of Excellence in Fort Lauderdale, TOI is targeting one of oncology's highest-need areas, as lung cancer remains among the deadliest cancer types. The center's focus on advanced diagnostics and innovative treatments aligns perfectly with TOI's value-based care model.
The recruitment of Dr. Edgardo Santos as the center's leader is particularly noteworthy. His international reputation and extensive experience at prestigious institutions like Tulane University and University of Miami positions TOI to attract both patients and potential clinical trial opportunities. This appointment demonstrates TOI's commitment to combining academic-level expertise with community-based delivery - a core differentiator in the competitive oncology space.
From an operational perspective, this expansion represents TOI's continued execution of its community-based specialty care strategy. By establishing centers of excellence in key markets, TOI can leverage clinical expertise while maintaining the cost advantages of community settings. This approach supports their value proposition to both patients and payers by potentially reducing the total cost of care while improving clinical outcomes for lung cancer patients.
The center's focus on clinical trials is especially relevant, as it creates additional revenue streams while positioning TOI at the forefront of innovative cancer treatments. This strengthens their competitive position against both academic centers and other community oncology groups that lack similar research capabilities.
CERRITOS, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, today announced the launch of its Lung Cancer Center of Excellence in Fort Lauderdale, Florida. The new center will be led by world-renowned thoracic oncologist Dr. Edgardo S. Santos Castillero, whose career has been defined by groundbreaking research, clinical excellence, and a deep commitment to patient care.
The Lung Cancer Center of Excellence provides patients across Florida with access to advanced treatments including clinical trials, delivered in a compassionate, community-based setting. By combining global expertise with local access, TOI delivers world-class cancer care and the personal connection of community oncology.
“Lung cancer remains one of the leading causes of cancer-related deaths, and patients deserve access to the latest therapies and expert care without the burden of traveling long distances,” said Dr. Santos. “At the Lung Cancer Center of Excellence, we bring advanced diagnostics, innovative treatments, and a whole-patient approach to South Florida so patients and their families can focus on healing.”
Dr. Santos, who has held leadership roles at Tulane University, the University of Miami/Sylvester Comprehensive Cancer Center, and the Lynn Cancer Institute, is internationally recognized as one of the foremost authorities in thoracic oncology. He has published extensively in peer-reviewed journals, serves on leadership committees for national and international oncology organizations, and is a sought-after speaker at oncology conferences worldwide.
“Our vision is to redefine lung cancer care by combining the most advanced value-based therapies with personalized, compassionate treatment,” said Daniel J. Virnich, Chief Executive Officer of The Oncology Institute. “The Lung Cancer Center of Excellence reflects TOI’s mission to expand access to high-quality cancer care across diverse communities, and improve clinical outcomes while lowering financial toxicity for patients and payor partners.”
About The Oncology Institute (www.theoncologyinstitute.com):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
FAQ
Who is leading TOI's new Lung Cancer Center of Excellence in Florida?
What services will TOI's Lung Cancer Center of Excellence offer?
How does TOI's new Lung Cancer Center align with their business strategy?
Where is TOI's new Lung Cancer Center of Excellence located?
What is Dr. Santos' background and expertise?
